Bb Biotech as of June 30, 2016
Portfolio Holdings for Bb Biotech
Bb Biotech holds 30 positions in its portfolio as reported in the June 2016 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Celgene Corporation | 14.1 | $356M | 3.6M | 98.63 | |
Incyte Corporation (INCY) | 12.1 | $307M | 3.8M | 79.98 | |
Gilead Sciences (GILD) | 9.1 | $232M | 2.8M | 83.42 | |
Ionis Pharmaceuticals (IONS) | 6.5 | $166M | 7.1M | 23.29 | |
Radius Health | 6.3 | $160M | 4.4M | 36.75 | |
Neurocrine Biosciences (NBIX) | 5.6 | $142M | 3.1M | 45.45 | |
Alexion Pharmaceuticals | 5.4 | $138M | 1.2M | 116.76 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 4.8 | $122M | 1.4M | 86.02 | |
Medivation | 4.7 | $120M | 2.0M | 60.30 | |
Agios Pharmaceuticals (AGIO) | 3.9 | $99M | 2.4M | 41.89 | |
Tesaro | 3.8 | $97M | 1.2M | 84.05 | |
Regeneron Pharmaceuticals (REGN) | 2.8 | $72M | 205k | 349.23 | |
Alnylam Pharmaceuticals (ALNY) | 2.6 | $66M | 1.2M | 55.49 | |
Halozyme Therapeutics (HALO) | 2.5 | $64M | 7.4M | 8.63 | |
Novavax | 2.4 | $61M | 8.3M | 7.27 | |
Juno Therapeutics | 2.0 | $50M | 1.3M | 38.44 | |
Alder Biopharmaceuticals | 1.7 | $42M | 1.7M | 24.97 | |
Kite Pharma | 1.5 | $38M | 750k | 50.00 | |
Intercept Pharmaceuticals In | 1.4 | $37M | 256k | 142.68 | |
Cempra | 1.3 | $34M | 2.0M | 16.49 | |
Intra Cellular Therapies (ITCI) | 1.1 | $27M | 700k | 38.82 | |
Sage Therapeutics (SAGE) | 1.0 | $26M | 851k | 30.13 | |
Macrogenics (MGNX) | 0.6 | $14M | 520k | 26.99 | |
Puma Biotechnology (PBYI) | 0.5 | $13M | 432k | 29.79 | |
Prothena (PRTA) | 0.5 | $12M | 350k | 34.96 | |
Achillion Pharmaceuticals | 0.4 | $10M | 1.3M | 7.80 | |
Esperion Therapeutics (ESPR) | 0.4 | $10M | 1.0M | 9.88 | |
Ptc Therapeutics I (PTCT) | 0.3 | $8.3M | 1.2M | 7.02 | |
Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.3 | $7.7M | 747k | 10.31 | |
Tobira Therapeutics Inc Common Stock Usd 0.0001 | 0.2 | $5.9M | 468k | 12.56 |